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We report on the first case in Ireland ofureteric
stentingwithshape-memoryalloynickel-titanium
(Memokath 051) stent in relieving malignant
ureteric obstruction. Successful drainage was
achieved and the patient required no further
intervention indicating a clear place for these
stents inthelong-termmanagementofmalignant
ureteric strictures. The use of ureteric double-J
stenting inthelong-termmanagementofureteric
obstruction is associated with well-recognized
complications. Consequently, metallic ureteric
stents weredevelopedtoovercometheassociated
morbidity. We report on the first case in Ireland
of ureteric stenting with shape-memory alloy
Nickel-Titanium (Memokath 051) stents.
CASE REPORT A 72-year-old woman with
inoperablegastroesophagealadenocarcinomawas
found to have bilateral hydronephrosis on
ultrasound scanning due to secondary disease.
Shehadpercutaneousnephrostomytubesinserted
and bilateral antegrade stenting with silastic
double-Jstents. Howeverherrenalfunctionbegan
todeteriorate afterthenephrostomy tubebecame
dislodged from the right kidney, which had 92%
differentialfunction.Thisshowedthatthesilastic
double-J stent was inadequate in draining the
obstructed right ureter. She subsequently had
bilateralpercutaneousantegrademetallicureteric
stenting (Fig. 1, Fig.2a and 2b). This was
successful in providing comfort and continued
ureteric drainage as monitored by her renal
function. She required no further intervention.
After six months ofpalliation, she succumbed to
her primary disease.
DISCUSSION
Long-term ureteric double-J stenting has been
the only viable option to open urinary diversion
inthemanagementofureteric obstruction caused
Fig 1. Postprocedure radiograph demonstrates position
of the bilateral Memokath ureteric stents prior to
removal of the nephrostomy drains.
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Fig 2a. Right nephrostogram showing phlanged upper
end oftheMemokath stent deployed in the ureter.
Fig 2b. Freedrainage ofthe ureterwith streamofcontrast
entering the bladder. Note the lower end of the
stent lies in the ureter and not the bladder to
prevent encrustation.
by recurrent benign disease or extrinsic
compression by tumours. However there are
recognisedcomplicationsincludingencrustation,
sepsis, haematuria, pain, reflux, fragmentation
and migration.' Double-J stents require regular
changes to maintain renal function, causing
repeated hospital admissions. Metallic ureteric
stents were developed to provide a solution to
long-term stenting without the aforementioned
complications.
Milroy et al reported the first use of metallic
stents in the urinary tract in treating urethral
strictures.2 These stents were then used in the
ureter for benign and malignant ureteric
strictures.3 However their usage in malignant
ureteric obstruction was hinderedby reocclusion
due to endothelial hyperplasia and tumour
ingrowththroughthe meshworkmakingremoval
virtuallyimpossible.4Anickel-titanium alloywas
then chosen to combat this because of the
resistanceoftitaniumtoencrustationintheurinary
tract.5
The stentsusedinthiscasewereMemokath® 051
(Engineers &DoctorsAIS, Hornbaek, Denmark).
The nickel and titanium alloy affords it a unique
thermal shape memory. It softens below 10°C
and reassumes its predetermined shape when
reheated to above 55°C. This can be repeated
with no resulting shape distortion. It also has a
tight spiral design to allow a degree of mobility
and prevent endothelial and tumour regrowth.
Initial experience of the Memokath 051 stent in
the ureter is found in two published series.
Kulkarni and Bellamy inserted 37 stents in 28
patients with ureteric strictures and followed
themuppostinsertionforameanof19.3 months.6
There was malignant disease in 18 patients and
benign pathology in 10 patients. Upper tract
decompression was achieved in all cases. Stent
migration was noted in 3 patients but only after
treatmentfortheirunderlyingmalignancy. There
were no other stent related problems. Arya et al
published a series of 13 stent insertions in 11
patients whohad ameanfollowupof 18 months.7
This group of patients had ureteric strictures
secondary to benign disease only. Once again
therewasreliefofobstruction andno stentrelated
symptoms.
These initial results show a clear place for these
stents inthelong-term management ofmalignant
ureteric strictures. Repeated stent changes are
avoided, easing pressure on hospital beds and
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resources. With 3-6monthlyhospital admissions
requiredforchangingindwellingdouble-Jstents,
there are obvious financial advantages as well as
advantages in patient comfort and hence quality
of life.
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